Comparison of pathological complete response (pCR) between short-term (<6 cycles) and long-term (≥6 cycles) neoadjuvant trastuzumab therapy for HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials
All content on this site: Copyright © 2025 AME Publishing Company. All rights are reserved. For all open access content, the Creative Commons licensing terms apply.
Published by AME Publishing Company
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Email: editor@glandsurgery.org
Comments (0)